![Gary Romano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Romano
No open positions remaining
Profile
Gary Romano formerly worked at ALS Hope Foundation, as Director, Janssen Global Services LLC, as Head-Development, Neurology & Alzheimer from 2013 to 2019, Passage Bio, Inc., as Chief Medical Officer from 2019 to 2021, and Alector, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Romano received his doctorate degree in 1988 from The Rockefeller University, doctorate degree in 1992 from The Johns Hopkins University School of Medicine, and undergraduate degree in 1982 from Trinity College.
Former positions of Gary Romano
| Companies | Position | End |
|---|---|---|
| ALECTOR, INC. | Chief Tech/Sci/R&D Officer | 25/04/2025 |
| PASSAGE BIO, INC. | Chief Tech/Sci/R&D Officer | 18/05/2021 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Corporate Officer/Principal | 01/09/2019 |
ALS Hope Foundation
 ALS Hope Foundation Miscellaneous Commercial ServicesCommercial Services Provides funding services for MDA/ALS centre of hope | Director/Board Member | - |
Training of Gary Romano
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College
 Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALS Hope Foundation
ALS Hope Foundation Miscellaneous Commercial ServicesCommercial Services Provides funding services for MDA/ALS centre of hope | Commercial Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Gary Romano
